Role of modeling and simulation in pediatric investigation plans

Paediatric Anaesthesia
Efthymios ManolisAgnès Saint Raymond


Ethical and practical constraints encourage the optimal use of resources in pediatric drug development. Modeling and simulation has emerged as a promising methodology acknowledged by industry, academia, and regulators. We previously proposed a paradigm in pediatric drug development, whereby modeling and simulation is used as a decision tool, for study optimization and/or as a data analysis tool. Three and a half years since the Paediatric Regulation came into force in 2007, the European Medicines Agency has gained substantial experience in the use of modeling and simulation in pediatric drug development. In this review, we present examples on how the proposed paradigm applies in real case scenarios of planned pharmaceutical developments. We also report the results of a pediatric database search to further 'validate' the paradigm. There were 47 of 210 positive pediatric investigation plan (PIP) opinions that made reference to modeling and simulation (data included all positive opinions issued up to January 2010). This reflects a major shift in regulatory thinking. The ratio of PIPs with modeling and simulation rose to two in five based on the summary reports. Population pharmacokinetic (POP-PK) and pharmacodynamics (POP-PD) and ...Continue Reading


Jun 3, 2000·Annual Review of Pharmacology and Toxicology·N H HolfordC C Peck
Sep 2, 2006·Statistics in Medicine·Deborah Ashby
Oct 22, 2009·British Journal of Clinical Pharmacology·Efthymios Manolis, Gérard Pons

❮ Previous
Next ❯


Feb 19, 2014·Pharmacogenomics·Anna-Karin Hamberg, Mia Wadelius
May 2, 2014·Nature Reviews. Drug Discovery·Peter Bauer, Franz König
Jun 3, 2014·The Journal of Nutrition, Health & Aging·Y AsahinaY Uyama
Aug 16, 2014·World Journal of Pediatrics : WJP·Wei ZhaoEvelyne Jacqz-Aigrain
May 12, 2015·Expert Opinion on Drug Metabolism & Toxicology·Janko SamardzicKarel Allegaert
Jul 19, 2011·Expert Opinion on Drug Metabolism & Toxicology·Andrea N Edginton, Ghanashyam Joshi
Jul 18, 2015·British Journal of Clinical Pharmacology·Paul G BaverelPiotr Kuna
Jul 4, 2015·Clinical Pharmacokinetics·Frederique RodieuxMarc Pfister
Aug 6, 2014·Orphanet Journal of Rare Diseases·Annemarie Rosan Kreeftmeijer-VegterPeter J de Vries
May 6, 2015·British Journal of Clinical Pharmacology·Francesco BellantiOscar Della Pasqua
Dec 18, 2013·British Journal of Clinical Pharmacology·Anna-Karin HambergE Niclas Jonsson
May 9, 2014·Paediatric Anaesthesia·Brian J Anderson, Tim Dare
Apr 25, 2015·Journal of Clinical Pharmacology·Jian WangGilbert J Burckart
Jun 23, 2015·Clinical Pharmacology and Therapeutics·K Allegaert, J van den Anker
Jul 24, 2014·British Journal of Clinical Pharmacology·Francesco BellantiOscar Della Pasqua
May 21, 2013·Toxicology Mechanisms and Methods·Dennis RokittaUwe Fuhr
Feb 22, 2014·Advanced Drug Delivery Reviews·M A TurnerUNKNOWN Global Research in Paediatrics
Nov 6, 2013·Advanced Drug Delivery Reviews·Hannah K BatchelorSandra Klein
Sep 20, 2016·British Journal of Clinical Pharmacology·Francesco BellantiUNKNOWN Consortium DEferiprone Evaluation in Paediatrics (DEEP)
Feb 26, 2016·Journal of Pediatric Gastroenterology and Nutrition·Jian WangDonna Griebel
Jan 31, 2018·Antimicrobial Agents and Chemotherapy·Yuma A BijleveldUNKNOWN PharmaCool Study Group
Jul 18, 2019·European Journal of Clinical Pharmacology·Sven C van DijkmanOscar Della Pasqua
Jan 20, 2012·Clinical Pharmacokinetics·Siv JönssonTomas Salmonson
Jan 21, 2016·Journal of Clinical Pharmacology·Francesco BellantiOscar Della Pasqua
Sep 8, 2011·Clinical Pharmacokinetics·Efthymios Manolis, Ralf Herold
Sep 1, 2013·Therapeutic Innovation & Regulatory Science·Tarek A LeilRonald Portman
Feb 16, 2011·Paediatric Anaesthesia·Brian J Anderson
Jun 7, 2012·Clinical Pharmacology and Therapeutics·J S BarrettB Meibohm
Mar 13, 2015·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Hong Lu, Sara Rosenbaum
Aug 21, 2013·Cancer Research·Mary F McGuireEddy Pasquier

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.